Cryoablation for older women with early breast cancer
Part of Cancer, Skin clinical trials.
This trial tests freezing small breast tumors with a probe (cryoablation) instead of surgery, for women aged 70 and older. It aims to find out if this less invasive treatment is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 70 years or older.
- You have a small (less than 2 cm), single breast tumor that shows up well on ultrasound.
- The tumor is at least 5 mm away from your skin, nipple, and chest wall.
- Your cancer is estrogen-receptor positive and HER2-negative.
- You can understand English or Dutch and agree to follow the study schedule.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a cold-based treatment (cryoablation) for certain brain tumors including gliomas, meningiomas, and metastases. It may be an option if you plan to have surgery and meet safety criteria.
This study compares freezing the tumor (cryoablation) versus surgical removal (lumpectomy) for early-stage breast cancer. It may be an option for women over 60 with a small, low-risk tumor.
This trial tests cryoablation (freezing the tumor with a needle) as a way to treat small, low-risk breast cancers without surgery. It is for women 50 or older whose cancers are hormone-receptor-positive and haven't spread to lymph nodes.
This trial compares a less invasive treatment called ablation (which uses extreme cold to destroy the tumor) with standard surgery for early-stage breast cancer. It is for women aged 50 or older with a small, low-risk tumor that has not spread.
This study tests if freezing a very small early-stage breast tumor (cryoablation) can be as effective as surgery. It may be an option for people whose tumor is small enough and hasn't spread to lymph nodes or elsewhere.
This study tests cryoablation (freezing) to treat small, early stage breast cancers that are hormone receptor positive and HER2 negative. It may be an option for postmenopausal women who want to avoid surgery.
Hear when a new Breast Cancer Stage I trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.